Legal & General Group »

Karyopharm Therapeutics shares owned by Legal & General Group

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Legal & General Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $19k 1.9k 9.77

More positions owned by Legal & General Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Micron Technology (MU)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Astrazeneca Ord (AZN)

View all positions for Legal & General Group

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics